Results of Extraordinary General Meeting - EGM - and changes to the Board

06/07/2007

6th July 2007 Announcement

Evolutec Group plc

(“Evolutec” or “Company”)

Results of Extraordinary General Meeting EGM and changes to the Board

At today’s EGM a resolution to adjourn the meeting was not passed and as a consequence, and as anticipated by the Board in its letter to shareholders dated 2 July 2007, the Resolutions to approve the voluntary winding up of the Company were put to the EGM and were not approved.

As planned, Nicholas Badman, Dr Mark Carnegie Brown, John Burke and Malcolm Darvell have stood down from the Board with effect from the end of the EGM. Dr David Bloxham and Graeme Hart will remain on the Board and the Company will proceed as an investment company with an investment strategy to seek a single investment, most probably of a UK or European business, in either the technology, healthcare or service related sectors.

It is expected that the two Directors proposed by Gartmore Investment Limited, Mark Hawtin and Gordon Hall, will be appointed to the Board shortly.

ENDS

Enquiries:

Evolutec - 0118 922 4480
David Bloxham, Chairman

Numis Securities Limited 020 7260 1000
Michael Meade

Financial Dynamics 020 7831 3113
David Yates
Ben Brewerton